Postoperative deterioration in health related quality of life as predictor for survival in patients with glioblastoma: A prospective study

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Jakola, Asgeir S ^a,b   Gulati, Sasha ^a,b   Weber, Clemens ^a   Unsgård, Geirmund ^a,b   Solheim, Ole ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPUTER ASSISTED SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; FOLLOW UP; GENERAL CONDITION DETERIORATION; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL TIME; TREATMENT DURATION; HEALTH; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; GLIOBLASTOMA; HEALTH; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 83055173770     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028592     Document Type: Article

References (37)

1. Solheim O, Selbekk T, Jakola AS, Unsgård G, (2010) Ultrasound-guided operations in unselected high-grade gliomas-overall results, impact of image quality and patient selection. Acta Neurochirurgica pp. 1-14.
2. Stummer W, Reulen H-J, Meinel T, Pichlmeier U, Schumacher W, et al. (2008) Extent of Resection and Survival in Glioblastoma Multiforme: Identification of and Adjustment for Bias. Neurosurgery 62: 564-576.
3. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, et al. (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. Journal of Neurosurgery 95: 190-198.
4. Sanai N, Polley M-Y, McDermott MW, Parsa AT, Berger MS, (2011) An extent of resection threshold for newly diagnosed glioblastomas. Journal of Neurosurgery 0: 1-6.
5. Gulati S, Jakola AS, Nerland US, Weber C, Solheim O, (2011) The risk of getting worse: Surgically acquired deficits, perioperative complications and functional outcomes after primary resection of glioblastoma. World Neurosurgery In press.
6. Cheng J-x, Zhang X, Liu B-L, (2009) Health-related quality of life in patients with high-grade glioma. Neuro Oncol 11: 41-50.
7. Jakola AS, Unsgård G, Solheim O, (2011) Quality of life in patients with intracranial gliomas: the impact of modern image-guided surgery. Journal of Neurosurgery 0: 1-9.
8. McGirt MJ, Mukherjee DM, Chaichana KL, Than KD, Weingart JD, et al. (2009) Association of Surgically Acquired Motor And Language Deficits on Overall Survival After Resection of Glioblastoma Multiforme. Neurosurgery 65: 463-470.
9. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, et al. (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. The Lancet Oncology 7: 392-401.
10. Unsgaard G, Rygh OM, Selbekk T, Müller TB, Kolstad F, et al. (2006) Intra-operative 3D ultrasound in neurosurgery. Acta Neurochirurgica 148: 235-253.
11. Gulati S, Berntsen EM, Solheim O, Kvistad KA, Håberg A, et al. (2009) Surgical Resection of High-grade Gliomas in Eloquent Regions Guided by Blood Oxygenation Level Dependent Functional Magnetic Resonance Imaging, Diffusion Tensor Tractography, and Intraoperative Navigated 3D Ultrasound. Minim Invasive Neurosurg 52: 17-24.
12. Rasmussen IA, Lindseth F, Rygh OM, Berntsen EM, Selbekk T, et al. (2007) Functional neuronavigation combined with intra-operative 3D ultrasound: Initial experiences during surgical resections close to eloquent brain areas and future directions in automatic brain shift compensation of preoperative data. Acta Neurochirurgica 149: 365-378.
13. The EuroQol Group (1990) EuroQol- a new facility for the measurement of health-related quality of life. Health Policy 16: 199-208.
14. Rabin R, Charro Fd, (2001) EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine 33: 337-343.
15. Burström K, Johannesson M, Diderichsen F, (2001) Swedish population health-related quality of life results using the EQ-5D. Quality of Life Research 10: 621-635.
16. Nord E, (1991) EuroQol©: health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy 18: 25-36.
17. Dolan PD, (1997) Modeling Valuations for EuroQol Health States. Medical Care 35: 1095-1108.
18. Lutterbach J, Bartelt S, Momm F, Becker G, Frommhold H, et al. (2005) Is older age associated with a worse prognosis due to different patterns of care? Cancer 103: 1234-1244.
19. Chaichana KL, Chaichana KK, Olivi A, Weingart JD, Bennett R, et al. (2011) Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Journal of Neurosurgery 114: 587-594.
20. Marina O, Suh JH, Reddy CA, Barnett GH, Vogelbaum MA, et al. (2011) Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Journal of Neurosurgery 0: 1-10.
21. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 352: 987-996.
22. Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, et al. (2007) Radiotherapy for Glioblastoma in the Elderly. N Engl J Med 356: 1527-1535.
23. Sanai N, Berger MS, (2008) Glioma Extent of Resection and its Impact on Patient Outcome. Neurosurgery 62: 753-766.
24. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, et al. (2010) Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group. Journal of Clinical Oncology 28: 1963-1972.
25. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ, (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. The Lancet Oncology 9: 453-461.
26. de Groot JF, Lamborn KR, Chang SM, Gilbert MR, Cloughesy TF, et al. (2011) Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study. Journal of Clinical Oncology.
27. McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, et al. (2009) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. Journal of Neurosurgery 110: 156-162.
28. Gotay CC, Kawamoto CT, Bottomley A, Efficace F, (2008) The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials. Journal of Clinical Oncology 26: 1355-1363.
29. Brown P, Ballman K, Rummans T, Maurer M, Sloan J, et al. (2006) Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas. Journal of Neuro-Oncology 76: 283-291.
30. Brown PDMD, Maurer MJMS, Rummans TAMD, Pollock BEMD, Ballman KVPD, et al. (2005) A Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas: The Impact of the Extent of Resection on Quality of Life and Survival. Neurosurgery 57: 495-504.
31. Quinten C, Coens C, Mauer M, Comte S, Sprangers MAG, et al. (2009) Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. The Lancet Oncology 10: 865-871.
32. Mauer M, Stupp R, Taphoorn MJB, Coens C, Osoba D, et al. (2007) The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study. Br J Cancer 97: 302-307.
33. Altman DG, Lausen B, Sauerbrei W, Schumacher M, (1994) Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors. Journal of the National Cancer Institute 86: 829-835.
34. Lydick E, Epstein RS, (1993) Interpretation of quality of life changes. Quality of Life Research 2: 221-226.
35. Chang SM, Parney IF, McDermott M, Barker FG 2nd, Schmidt MH, et al. (2003) Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98: 1175-1181.
36. Ibañez FAL, Hem S, Ajler P, Vecchi E, Ciraolo C, et al. (2011) A New Classification of Complications in Neurosurgery. World Neurosurgery 75: 709-715.
37. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, et al. (1998) Neurosurgical Outcomes in a Modern Series of 400 Craniotomies for Treatment of Parenchymal Tumors. Neurosurgery 42: 1044-1055.